Clinical TrialsSearch results
Number of results: 616
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Exploring the Safety and Effectiveness of Combined Azacitidine and Ruxolitinib Therapy for Acute Erythroid Leukemia
- AML with erythroid predominance or genomic abnormalities associated with activatd JAK-STAT signaling
- Kanda Junya
- 2024-07-17
Recruiting
- A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
- Hidradenitis Suppurativa
- Ono Shintaro
- 2024-07-12
Recruiting
- Investigation of the Clinical Utility of [68Ga]Ga-NeoB PET in the Diagnosis of Gastrointestinal Cancers
- gastrointestinal malignancy (esophageal, gastric, or colorectal cancer)
- Nakamoto Yuji
- 2024-07-12
Recruiting
- Safety and effectiveness of preoperative chemotherapy for obstructive colon cancer with endoscopic stent placement
- Obstructive colon cancer
- Obama Kazutaka
- 2024-06-27
Recruiting
- A Multicentre, Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Flow Diverters (PFMD-001) for Cerebral Aneurysms
- cerebral aneurysm
- Arakawa Yoshiki
- 2024-06-24
Recruiting
- next generation MRI imaging technique
- Any diseases MRI is considered to be helpful
- Okuchi Sachi
- 2024-06-24
Recruiting
- Clinical Trial of Evaluating Efficacy and Safety for Percutaneously Prostate Cancer Lesion Targeted Microwave Tissue Coagulation as Prostate Functional Preservation
- Localized Prostate Cancer
- Ukimura Osamu
- 2024-05-01
Recruiting
- Preventive Effect of Remimazolam on Emergence Agitation in Children
- Emergence delirium
- Kimura Satoshi
- 2024-04-16
Recruiting
- Phase II trial of stereotactic radiotherapy for patients with head and neck cancer
- Head and neck cancer
- Nakashima Ryota
- 2024-04-10
Recruiting
- A Multicentre, Single-arm Study to Assess the Safety and Efficacy of Recanalisation Therapy for Acute Ischaemic Stroke Using Dilators
- acute ischemic stroke
- Arakawa Yoshiki
- 2024-03-29